Amedisys Q2 revenue $621.9M; adjusted EPS $1.54 vs $1.32; merger expenses $26.3M

AMEDISYS INC

2025-Q2 EPS reported $2.68 revenue$1,216,642,000

Net service revenue $621.9M, up $30.7M (+5.2%) from $591.2M in Q2 2024.
Net income $28.1M ($0.84 diluted EPS) versus $32.3M ($0.98) prior year; includes $26.3M merger-related expenses.
Adjusted EBITDA $80.8M vs $73.2M; adjusted net income $51.4M ($1.54 per share) vs $43.5M ($1.32).
Six-month revenue $1,216.6M, adjusted EBITDA $149.6M; $48.1M gain on equity method investment recorded.
Merger expenses totaled $43.0M year-to-date; no guidance update provided in this release.

item 2.02item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.